A new smoking cessation 'cascade' among women with or at risk for HIV infection.


Journal

AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219

Informations de publication

Date de publication:
01 01 2022
Historique:
pubmed: 30 9 2021
medline: 26 3 2022
entrez: 29 9 2021
Statut: ppublish

Résumé

The aim of this study was to define a smoking cessation 'cascade' among USA women with and without HIV and examine differences by sociodemographic characteristics. An observational cohort study using data from smokers participating in the Women's Interagency HIV Study between 2014 and 2019. We followed 1165 women smokers with and without HIV from their first study visit in 2014 or 2015 until an attempt to quit smoking within approximately 3 years of follow-up, initial cessation (i.e. no restarting smoking within approximately 6 months of a quit attempt), and sustained cessation (i.e. no restarting smoking within approximately 12 months of a quit attempt). Using the Aalen-Johansen estimator, we estimated the cumulative probability of achieving each step, accounting for the competing risk of death. Forty-five percent of smokers attempted to quit, 27% achieved initial cessation, and 14% achieved sustained cessation with no differences by HIV status. Women with some post-high school education were more likely to achieve each step than those with less education. Outcomes did not differ by race. Thirty-six percent [95% confidence interval (95% CI): 31-42] of uninsured women attempted to quit compared with 47% (95% CI: 44-50) with Medicaid and 49% (95% CI: 41-59) with private insurance. To decrease smoking among USA women with and without HIV, targeted, multistage interventions, and increased insurance coverage are needed to address shortfalls along this cascade.

Identifiants

pubmed: 34586086
doi: 10.1097/QAD.0000000000003089
pii: 00002030-202201010-00012
pmc: PMC8819357
mid: NIHMS1773361
doi:

Types de publication

Journal Article Observational Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

107-116

Subventions

Organisme : NHLBI NIH HHS
ID : U01 HL146245
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146208
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146192
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146242
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146193
Pays : United States
Organisme : NIAID NIH HHS
ID : K01 AI125087
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146194
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146241
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027767
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI050409
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146333
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146205
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH116867
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI073961
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146201
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG059505
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146204
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146202
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001881
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000004
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146240
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146203
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003098
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI050410
Pays : United States

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Références

United States Public Health Service Office of the Surgeon General; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. Smoking cessation: a report of the surgeon general . Washington, DC: US Department of Health and Human Services; 2020.
Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, et al. 21st-century hazards of smoking and benefits of cessation in the United States . N Engl J Med 2013; 368:341–350.
Cropsey KL, Willig JH, Mugavero MJ, Crane HM, McCullumsmith C, Lawrence S, et al. Cigarette smokers are less likely to have undetectable viral loads: results from four HIV Clinics . J Addict Med 2016; 10:13–19.
Frazier EL, Sutton MY, Brooks JT, Shouse RL, Weiser J. Trends in cigarette smoking among adults with HIV compared with the general adult population, United States - 2009–2014 . Prev Med 2018; 111:231–234.
Vijayaraghavan M, Yuan P, Gregorich S, Lum P, Appelle N, Napoles AM, et al. Disparities in receipt of 5As for smoking cessation in diverse primary care and HIV clinics . Prev Med Rep 2017; 6:80–87.
Calvo-Sánchez M, Perelló R, Pérez I, Mateo MG, Junyent M, Laguno M, et al. Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studies . HIV Med 2013; 14:40–48.
Healthy People 2030 | health.gov. https://health.gov/healthypeople [Accessed 5 April 2021].
Reddy KP, Kong CY, Hyle EP, Baggett TP, Huang M, Parker RA, et al. Lung cancer mortality associated with smoking and smoking cessation among people living with HIV in the United States . JAMA Intern Med 2017; 177:1613–1621.
Helleberg M, Afzal S, Kronborg G, Larsen CS, Pedersen G, Pedersen C, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study . Clin Infect Dis 2013; 56:727–734.
Westreich D, Cates J, Cohen M, Weber KM, Seidman D, Cropsey K, et al. Smoking, HIV, and risk of pregnancy loss . AIDS 2017; 31:553–560.
Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US). How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general . Atlanta, GA: Centers for Disease Control and Prevention (US); 2010.
Breger TL, Edwards JK, Cole SR, Saag M, Rebeiro PF, Moore RD, et al. Estimating a set of mortality risk functions with multiple contributing causes of death . Epidemiology 2020; 31:704–712.
Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection . Clin Infect Dis 2011; 52:793–800.
Pence BW, O’Donnell JK, Gaynes BN. The Depression Treatment Cascade in primary care: a public health perspective . Curr Psychiatry Rep 2012; 14:328–335.
Gelberg L, Andersen RM, Leake BD. The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people . Health Serv Res 2000; 34:1273–1302.
D'Souza G, Bhondoekhan F, Benning L, Margolick JB, Adedimeji AA, Adimora AA, et al. Characteristics of the MACS/WIHS Combined Cohort Study: opportunities for research on aging with HIV in the longest US observational study of HIV . Am J Epidemiol 2021; 190:1457–1475.
Adimora AA, Ramirez C, Benning L, Greenblatt RM, Kempf M-C, Tien PC, et al. Cohort profile: the Women's Interagency HIV Study (WIHS) . Int J Epidemiol 2018; 47:393–394i.
Zalla LC, Edwards JK, Cole SR, Rudolph JE, Breger TL, Virkud A, et al. Demographic trends in US HIV diagnoses, 2008–2017 . Data Movies Am J Public Health 2021; 111:529–532.
Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers . Addiction 2004; 99:29–38.
Babb S, Malarcher A, Schauer G, Asman K, Jamal A. Quitting smoking among adults — United States, 2000–2015 . MMWR Morb Mortal Wkly Rep 2017; 65:1457–1464.
Aalen OO, Johansen S. An empirical transition matrix for non-homogeneous Markov chains based on censored observations . Scand J Stat 1978; 5:141–150.
Schenker N, Gentleman JF. On judging the significance of differences by examining the overlap between confidence intervals . Am Stat 2001; 55:182–186.
Petoumenos K, Worm S, Reiss P, de Wit S, d’Arminio Monforte A, Sabin C, et al. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(∗) . HIV Med 2011; 12:412–421.
Martín Cantera C, Puigdomènech E, Ballvé JL, Arias OL, Clemente L, Casas R, et al. Effectiveness of multicomponent interventions in primary healthcare settings to promote continuous smoking cessation in adults: a systematic review . BMJ Open 2015; 5:e008807.
Silfen SL, Cha J, Wang JJ, Land TG, Shih SC. Patient characteristics associated with smoking cessation interventions and quit attempt rates across 10 community health centers with electronic health records . Am J Public Health 2015; 105:2143–2149.
Trinidad DR, Pérez-Stable EJ, White MM, Emery SL, Messer K. A nationwide analysis of US racial/ethnic disparities in smoking behaviors, smoking cessation, and cessation-related factors . Am J Public Health 2011; 101:699–706.
King G, Polednak A, Bendel RB, Vilsaint MC, Nahata SB. Disparities in smoking cessation between African Americans and whites . Am J Public Health 2004; 94:1965–1971.
United States Bureau of the Census; United States Bureau of Labor Statistics. Current Population Survey: Annual Social and Economic Supplement (ASEC), United States, 2019 . Inter-university Consortium for Political and Social Research [distributor]; 2020.
Hessol NA, Weber KM, D'Souza G, Burton D, Young M, Milam J, et al. Smoking cessation and recidivism in the Women's Interagency Human Immunodeficiency Virus Study . Am J Prev Med 2014; 47:53–69.
Akhtar-Khaleel WZ, Cook RL, Shoptaw S, Surkan P, Stall R, Beyth RJ, et al. Trends and predictors of cigarette smoking among HIV seropositive and seronegative men: the Multicenter Aids Cohort Study . AIDS Behav 2016; 20:622–632.
Schäfer J, Young J, Bernasconi E, Ledergerber B, Nicca D, Calmy A, et al. Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort Study . HIV Med 2015; 16:3–14.
Goldberg D, Weber KM, Orsi J, Hessol NA, D'Souza G, Watts DH, et al. Smoking cessation among women with and at risk for HIV: are they quitting? . J Gen Intern Med 2010; 25:39–44.
McAfee T, Babb S, McNabb S, Fiore MC. Helping smokers quit: opportunities created by the Affordable Care Act . N Engl J Med 2015; 372:5–7.
Young K, Quinn K, Frazier E, Jan 07 JSP, 2014. Assessing the impact of the Affordable Care Act on health insurance coverage of people with HIV. KFF. 2014. https://www.kff.org/hivaids/issue-brief/assessing-the-impact-of-the-affordable-care-act-on-health-insurance-coverage-of-people-with-hiv/ . [Accessed 5 April 2021].
Ludema C, Cole SR, Eron JJ, Holmes GM, Anastos K, Cocohoba J, et al. Health insurance type and control of hypertension among US women living with and without HIV infection in the Women's Interagency HIV Study . Am J Hypertens 2017; 30:594–601.
DiGiulio A, Jump Z, Babb S, Schecter A, Williams K-AS, Yembra D, Armour BS. State Medicaid coverage for tobacco cessation treatments and barriers to accessing treatments — United States, 2008–2018 . MMWR Morb Mortal Wkly Rep 2018; 67:155–160.

Auteurs

Tiffany L Breger (TL)

Department of Medicine, University of North Carolina School of Medicine,Chapel Hill.

Daniel Westreich (D)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, at Chapel Hill, North Carolina.

Andrew Edmonds (A)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, at Chapel Hill, North Carolina.

Jessie K Edwards (JK)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, at Chapel Hill, North Carolina.

Lauren C Zalla (LC)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, at Chapel Hill, North Carolina.

Stephen R Cole (SR)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, at Chapel Hill, North Carolina.

Catalina Ramirez (C)

Department of Medicine, University of North Carolina School of Medicine,Chapel Hill.

Igho Ofotokun (I)

Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.

Seble G Kassaye (SG)

Department of Medicine, Georgetown University, Washington, District of Columbia.

Todd T Brown (TT)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Deborah Konkle-Parker (D)

Department of Medicine, School of Nursing, University of Mississippi, Jackson, MS.

Deborah L Jones (DL)

Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida.

Gypsyamber D'Souza (G)

Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.

Mardge H Cohen (MH)

Department of Medicine, Stroger Hospital of Cook County Health and Hospitals System, Chicago, Illinois.

Phyllis C Tien (PC)

Department of Medicine, University of California San Francisco, and Department of Veterans Affairs, San Francisco, California.

Tonya N Taylor (TN)

Department of Medicine, SUNY Downstate Health Sciences University, Brooklyn.

Kathryn Anastos (K)

Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.

Adaora A Adimora (AA)

Department of Medicine, University of North Carolina School of Medicine,Chapel Hill.
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, at Chapel Hill, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH